Novelix Pharmaceuticals Ltd to Hold Board Meeting to Approve Q1 2026 Financial Results and Review Report
Novelix Pharmaceuticals Ltd has scheduled a meeting of its Board of Directors on Thursday, August 13, 2026. The meeting is set to address the approval of the company's financial performance for the quarter ending June 30, 2026.The primary agenda item for the board includes considering and approving the unaudited standalone financial results for the quarter ended on June 30, 2026. Additionally, the meeting is scheduled to review the limited report provided by the auditors.
In light of this corporate event, Novelix Pharmaceuticals Ltd has also restricted insider trading. The designated trading window for the company's Designated Persons and their immediate relatives has been closed starting from July 01, 2026. This trading restriction will remain in effect until forty-eight hours following the conclusion of the Board of Directors meeting.
Novelix Pharmaceuticals is noted to be formerly known as TRIMURTHI LIMITED.
Stock Price Movement
Novelix Pharmaceuticals Ltd settled at ₹70.74 on Friday after the shares slipped 4.04%.The stock traded throughout the session, moving within a range that spanned from an intraday low of ₹70.10 to a high of ₹77.00.
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.